TMDIF vs. VERO, TNON, VAPO, STSS, INVO, QNRX, IONM, AVGR, GMVDF, and AEMD
Should you be buying Titan Medical stock or one of its competitors? The main competitors of Titan Medical include Venus Concept (VERO), Tenon Medical (TNON), Vapotherm (VAPO), Sharps Technology (STSS), INVO Bioscience (INVO), Quoin Pharmaceuticals (QNRX), Assure (IONM), Avinger (AVGR), G Medical Innovations (GMVDF), and Aethlon Medical (AEMD). These companies are all part of the "surgical & medical instruments" industry.
Titan Medical (NASDAQ:TMDIF) and Venus Concept (NASDAQ:VERO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and community ranking.
Titan Medical has higher earnings, but lower revenue than Venus Concept. Venus Concept is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.
In the previous week, Venus Concept had 7 more articles in the media than Titan Medical. MarketBeat recorded 8 mentions for Venus Concept and 1 mentions for Titan Medical. Titan Medical's average media sentiment score of 0.69 beat Venus Concept's score of 0.15 indicating that Titan Medical is being referred to more favorably in the media.
Venus Concept received 34 more outperform votes than Titan Medical when rated by MarketBeat users.
Titan Medical has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500. Comparatively, Venus Concept has a beta of 0.65, indicating that its stock price is 35% less volatile than the S&P 500.
0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 87.4% of Venus Concept shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by company insiders. Comparatively, 51.4% of Venus Concept shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Titan Medical has a net margin of 0.00% compared to Venus Concept's net margin of -51.00%. Titan Medical's return on equity of 126.94% beat Venus Concept's return on equity.
Summary
Titan Medical beats Venus Concept on 9 of the 14 factors compared between the two stocks.
Get Titan Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for TMDIF and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TMDIF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
TMDIF vs. The Competition
Titan Medical Competitors List
Related Companies and Tools
